239 related articles for article (PubMed ID: 36313286)
1. Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma.
Zhou L; Zhan W; Wei X
Front Pharmacol; 2022; 13():1015338. PubMed ID: 36313286
[TBL] [Abstract][Full Text] [Related]
2. PTGFR and SLCO2A1 Gene Polymorphisms Determine Intraocular Pressure Response to Latanoprost in Han Chinese Patients with Glaucoma.
Zhang P; Jiang B; Xie L; Huang W
Curr Eye Res; 2016 Dec; 41(12):1561-1565. PubMed ID: 27336732
[TBL] [Abstract][Full Text] [Related]
3. Association between SNPs of Metalloproteinases and Prostaglandin F2α Receptor Genes and Latanoprost Response in Open-Angle Glaucoma.
Ussa F; Fernandez I; Brion M; Carracedo A; Blazquez F; Garcia MT; Sanchez-Jara A; De Juan-Marcos L; Jimenez-Carmona S; Juberias JR; Martinez-de-la-Casa JM; Pastor JC
Ophthalmology; 2015 May; 122(5):1040-8.e4. PubMed ID: 25704319
[TBL] [Abstract][Full Text] [Related]
4. Correlations of AFAP1, GMDS and PTGFR gene polymorphisms with intra-ocular pressure response to latanoprost in patients with primary open-angle glaucoma.
Cui XJ; Zhao AG; Wang XL
J Clin Pharm Ther; 2017 Feb; 42(1):87-92. PubMed ID: 27862086
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin analog treatment of glaucoma and ocular hypertension.
Alexander CL; Miller SJ; Abel SR
Ann Pharmacother; 2002 Mar; 36(3):504-11. PubMed ID: 11895065
[TBL] [Abstract][Full Text] [Related]
7. Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues.
El Ameen A; Vandermeer G; Khanna RK; Pisella PJ
Eur J Ophthalmol; 2019 Nov; 29(6):645-653. PubMed ID: 30301370
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between polymorphisms in the prostaglandin F2α receptor and solute carrier organic anion transporter family 2A1 genes and intraocular pressure response to prostaglandin analogs.
McCarty CA; Berg R; Patchett R; Wilke RA; Burmester JK
Ophthalmic Genet; 2012 Jun; 33(2):74-6. PubMed ID: 22060278
[TBL] [Abstract][Full Text] [Related]
9. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
[TBL] [Abstract][Full Text] [Related]
10. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
Schwartz GF; Tan J; Kotak S
J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
[TBL] [Abstract][Full Text] [Related]
12. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
Reardon G; Schwartz GF; Mozaffari E
Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis.
Tang W; Zhang F; Liu K; Duan X
Medicine (Baltimore); 2019 Jul; 98(30):e16597. PubMed ID: 31348303
[TBL] [Abstract][Full Text] [Related]
14. Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective.
Schmier JK; Covert DW; Robin AL
Curr Med Res Opin; 2007 Nov; 23(11):2867-75. PubMed ID: 17922980
[TBL] [Abstract][Full Text] [Related]
15. Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
Mishra D; Sinha BP; Kumar MS
Korean J Ophthalmol; 2014 Oct; 28(5):399-407. PubMed ID: 25276082
[TBL] [Abstract][Full Text] [Related]
16. Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy.
Miki T; Naito T; Fujiwara M; Araki R; Kiyoi R; Shiode Y; Fujiwara A; Morizane Y; Shiraga F
PLoS One; 2017; 12(7):e0181550. PubMed ID: 28727804
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.
Covert D; Robin AL
Curr Med Res Opin; 2006 May; 22(5):971-6. PubMed ID: 16709319
[TBL] [Abstract][Full Text] [Related]
19. Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension.
Orme M; Collins S; Dakin H; Kelly S; Loftus J
Curr Med Res Opin; 2010 Mar; 26(3):511-28. PubMed ID: 20014995
[TBL] [Abstract][Full Text] [Related]
20. Latanoprost in the treatment of glaucoma.
Alm A
Clin Ophthalmol; 2014; 8():1967-85. PubMed ID: 25328381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
